Anavex Life Sciences Corp.AVXLNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-0.56
Operating CF/Share$-0.43
Free CF/Share$-0.43
Cash/Share$1.18
Book Value/Share$1.07
Tangible Book/Share$1.07
Equity/Share$1.07
Interest Debt/Share$0.00
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$403.85M
Enterprise Value$302.69M
P/E Ratio-8.01P/S Ratio0.00P/OCF Ratio-10.40
P/FCF Ratio-10.89
P/B Ratio4.24P/TB Ratio4.24
EV/Sales0.00EV/EBITDA-5.24
Graham Valuation
Graham Number--
Graham Net-Net$1.06
Profitability
Earnings Yield-12.48%FCF Yield-9.19%ROE-45.67%ROIC-60.26%Return on Tangible Assets-47.03%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00Debt/Market Cap0.00
Net Debt/EBITDA1.75
Current Ratio8.82Interest Coverage0.00xIncome Quality0.77Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$90.96M
Working Capital$89.69M
Invested Capital$89.69M
Intangibles/Assets0.00%